期刊文献+
共找到31篇文章
< 1 2 >
每页显示 20 50 100
From Diagnosis to Recurrence: Primary Cardiac Myxofibrosarcoma, A Diagnostic and Therapeutic Challenge
1
作者 Maria Jose Santa-Ana-Bayona Camila Ponce-Acosta +6 位作者 Gilberto H. Gutierrez-Acosta Pavel Martinez-Dominguez Mauricio Garcia-Cardenas Enrique Ruiz-Mori Enrique C. Guerra Ruben Alejandro Leon-Laredo Nilda Espinola-Zavaleta 《World Journal of Cardiovascular Diseases》 2024年第12期723-729,共7页
Introduction: Primary cardiac myxofibrosarcoma (MFS) is a rare and aggressive malignancy, with limited treatment options and a high recurrence rate. Multimodal imaging is critical for diagnosis, and surgery remains th... Introduction: Primary cardiac myxofibrosarcoma (MFS) is a rare and aggressive malignancy, with limited treatment options and a high recurrence rate. Multimodal imaging is critical for diagnosis, and surgery remains the primary treatment, though recurrence is common. Case Presentation: We present the case of a 41-year-old male with history of intermittent chest pain and palpitations. Initial work-up revealed a left atrial mass, which after thorough evaluation with multimodal imaging and histopathological assessment, was diagnosed as a primary cardiac myxofibrosarcoma. Despite complete surgical resection and low-grade histology, recurrence ensued, prompting reintervention and adjuvant radiotherapy. Discussion: Cardiac MFS poses significant diagnostic challenges. Multimodal imaging and immunohistochemistry are key to diagnosis. While surgery is the mainstay of treatment, high recurrence rates necessitate consideration of adjuvant therapies and long-term monitoring. Conclusion: This case highlights the importance of differential diagnosis of intracardiac masses, as well as reaching a consensus regarding the approach for malignant cardiac tumors. 展开更多
关键词 myxofibrosarcoma Primary Cardiac Tumors Left Atrial Mass Multimodal Imaging
暂未订购
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 被引量:3
2
作者 Maristella Saponara Valentina Indio +16 位作者 Carmine Pizzi Elena-Daniela Serban Milena Urbini Annalisa Astolfi Pasquale Paolisso Sofia Martin Suarez Margherita Nannini Davide Pacini Valentina Agostini Ornella Leone Valentina Ambrosini Giuseppe Tarantino Stefano Fanti Fabio Niro Francesco Buia Domenico Attinà Maria Abbondanza Pantaleo 《World Journal of Clinical Cases》 SCIE 2019年第19期3018-3026,共9页
BACKGROUND Cardiac tumors are rare and complex entities.Surgery represents the cornerstone of therapy,while the role of adjuvant treatment remains unclear and,in case of relapse or metastatic disease,the prognosis is ... BACKGROUND Cardiac tumors are rare and complex entities.Surgery represents the cornerstone of therapy,while the role of adjuvant treatment remains unclear and,in case of relapse or metastatic disease,the prognosis is very poor.Lack of prospective,randomized clinical trials hinders the generation of high level evidence for the optimal diagnostic workup and multimodal treatment of cardiac sarcomas.Herein,we describe the multidisciplinary clinical management and molecular characterization of a rare case of cardiac myxofibrosarcoma in an elderly woman.CASE SUMMARY A 73-year-old woman presented signs and symptoms of acute left-sided heart failure.Imaging examination revealed a large,left atrial mass.With suspicion of a myxoma,she underwent surgery,and symptoms were promptly relieved.Histology showed a cardiac myxofibrosarcoma,a rare histotype of cardiac sarcoma.Eight months later,disease unfortunately relapsed,and after a multidisciplinary discussion,a chemotherapy with doxorubicin and then gemcitabine was started,achieving partial radiologic and complete metabolic response,which was maintained up to 2 years and is still present.This report is focused on the entire clinical path of our patient from diagnosis to follow-up,through surgery and strategies adopted at relapse.Moreover,due to their rarity,very little is known about the molecular landscape of myxofibrosarcomas.Thus,we also performed and described preliminary genome analysis of the tumor tissue to get further insight on mechanisms involved in tumor growth,and to possibly unveil new clinically actionable targets.CONCLUSION We report a case of cardiac myxofibrosarcoma that achieved a very good prognosis due to an integrated surgical,cardiac and oncologic treatment strategy. 展开更多
关键词 CARDIAC SARCOMA myxofibrosarcoma WHOLE transcriptome sequencing DOXORUBICIN GEMCITABINE Case report
暂未订购
Myxofibrosarcoma of the scalp with difficult preoperative diagnosis:A case report and review of the literature
3
作者 Xiao-Ting Ke Xiong-Feng Yu +3 位作者 Ji-Yang Liu Fang Huang Mei-Gui Chen Qing-Quan Lai 《World Journal of Clinical Cases》 SCIE 2020年第11期2350-2358,共9页
BACKGROUND A myxofibrosarcoma(MFS)is a malignant fibroblastic tumor that tends to occur in the lower and upper extremities.The reported incidence of head and neck MFSs is extremely rare.We report a 46-year-old male w... BACKGROUND A myxofibrosarcoma(MFS)is a malignant fibroblastic tumor that tends to occur in the lower and upper extremities.The reported incidence of head and neck MFSs is extremely rare.We report a 46-year-old male with“a neoplasm in the scalp”who was hospitalized and diagnosed with an MFS(highly malignant with massive necrotic lesions)based on histologic and immunohistochemistry evaluations.The magnetic resonance imaging manifestations did not demonstrate the“tail sign”mentioned in several studies,which resulted in a great challenge to establish an imaging diagnosis.The treatment plan is closely associated with the anatomic location and histologic grade,and more importantly,aggressive surgery and adjuvant radiotherapy may be helpful.Hence,we report the case and share some valuable information about the disease.CASE SUMMARY A 46-year-old male with“a neoplasm in the scalp for 6 mo”was hospitalized.Initially,the tumor was about the size of a soybean,without algesia or ulceration.The patient ignored the growth,did not seek treatment,and thus,did not receive treatment.Recently,the tumor increased to the size of an egg;there was no bleeding or algesia.His family history was unremarkable.No abnormalities were found upon laboratory testing,including routine hematologic,biochemistry,and tumor markers.Computed tomography showed an ovoid mass(6.25 cm×3.29 cm×3.09 cm in size)in the left frontal scalp with low density intermingled with equidense strips in adjacent areas of the scalp.Magnetic resonance imaging revealed a lesion with an irregular surface and an approximate size of 3.55 cm×6.34 cm in the left frontal region,with clear boundaries and visible separation.Adjacent areas of the skull were damaged and the dura mater was involved.Contrast enhancement showed an uneven enhancement pattern.Surgery was performed and postoperative adjuvant radiotherapy was administered to avoid recurrence or metastasis.The post-operative pathologic diagnosis confirmed an MFS.A repeat computed tomography scan showed no local recurrence or distant metastasis 19 mo post-operatively.CONCLUSION The case reported herein of MFS was demonstrated in an extremely rare location on the scalp and had atypical magnetic resonance imaging findings,which serves as a reminder to radiologists of the possibility of this diagnosis to assist in clinical treatment.Given the special anatomic location and the high malignant potential of this rare tumor,combined surgical and adjuvant radiotherapy should be considered to avoid local recurrence and distant metastasis.The significance of regular follow-up is strongly recommended to improve the long-term survival rate. 展开更多
关键词 Malignant fibrous histiocytoma myxofibrosarcoma SCALP Magnetic resonance imaging TREATMENT Case report
暂未订购
Giant myxofibrosarcoma of the esophagus treated by endoscopic submucosal dissection:A case report
4
作者 Xiao-Song Wang Cheng-Guang Zhao +1 位作者 Hui-Ming Wang Xiao-Yan Wang 《World Journal of Clinical Cases》 SCIE 2023年第5期1094-1098,共5页
BACKGROUND Myxofibrosarcoma(MFS)is a fibroblast-derived sarcoma that mainly occurs in subcutaneous tissue.MFS rarely occurs in the gastrointestinal tract,especially in the esophagus.CASE SUMMARY A 79-year-old male pat... BACKGROUND Myxofibrosarcoma(MFS)is a fibroblast-derived sarcoma that mainly occurs in subcutaneous tissue.MFS rarely occurs in the gastrointestinal tract,especially in the esophagus.CASE SUMMARY A 79-year-old male patient was admitted to our hospital for dysphagia for a week.Computed tomography and electronic gastroscopy showed that a giant mass was located 30 cm from the incisor and extended to the cardia.There was incomplete esophageal stenosis.Endoscopic pathology showed spindle cell lesions,which were considered inflammatory myofibroblast like hyperplasia.Considering the strong demands of the patient and his family,and the fact that most inflammatory myofibroblast tumors are benign,we decided to perform endoscopic submucosal dissection(ESD)even if the tumor size was giant(9.0 cm×3.0 cm).Postoperative pathological examination resulted in a final diagnosis of MFS.MFS rarely occurs in the gastrointestinal tract,especially in the esophagus.Surgical resection and local adjuvant radiotherapy are the first choices to improve the prognosis.This case report firstly described the ESD for esophageal giant MFS.It suggests that ESD may be an alternative treatment for primary esophageal MFS.CONCLUSION This case report for the first time describe the successful treatment of a giant esophageal MFS by ESD,suggesting that ESD may be an alternative treatment for primary esophageal MFS,especially in elderly high-risk patients with obvious dysphagia symptoms. 展开更多
关键词 Endoscopic submucosal dissection Giant myxofibrosarcoma ESOPHAGUS Case report
暂未订购
High-Grade Extremity Myxofibrosarcoma with Synchronous Mesenteric Leiomyosarcoma: Double Primary Sarcomas
5
作者 Milljae Shin Sung-Joo Kim 《Surgical Science》 2013年第8期345-349,共5页
Here, we report the case of a 47-year-old male who presented with a painless palpable mass in the right shoulder. This extremity tumor was diagnosed as a high-grade myxofibrosarcoma after a wide excision. Simultaneous... Here, we report the case of a 47-year-old male who presented with a painless palpable mass in the right shoulder. This extremity tumor was diagnosed as a high-grade myxofibrosarcoma after a wide excision. Simultaneously, a synchronous mesenteric mass was discovered, which proved to be a leiomyosarcoma. 展开更多
关键词 DOUBLE PRIMARY LEIOMYOSARCOMA myxofibrosarcoma SYNCHRONOUS Sarcoma
暂未订购
Unexpected Metastatic Recurrent Myxofibrosarcoma: A Scenario That May Be More Common than You Think
6
作者 Carrillo-Pinto Laura Cruz-Méndez Adriana +2 位作者 Ucán-Gamboa Dioney Flores-López Alejandro Gutiérrez-Palma Ximena 《Surgical Science》 2023年第11期667-672,共6页
Soft tissue sarcomas represent only 1% of all adult cancers;myxofibrosarcoma is the most common type that arises in adult extremities, particularly lower limbs (77%), other less common locations are the trunk (12%) an... Soft tissue sarcomas represent only 1% of all adult cancers;myxofibrosarcoma is the most common type that arises in adult extremities, particularly lower limbs (77%), other less common locations are the trunk (12%) and neck (3%). Usually presenting as a painless, subcutaneous, slow growing mass with tendency for recurrence, they are prone to have higher histological grade and metastatic potential after recurrence;even in optimal multidisciplinary settings patients can have incomplete resections, making metastatic disease more common after misdiagnosis. We present the case of a 69-year-old male patient with a right infraescapular tumor, presenting as a painless 15 × 8 cm, mobile mass, with a slow but progressive growth, history of a previous tumor excised at the same location 5 years prior without histopathological report. 展开更多
关键词 Case Report myxofibrosarcoma Metastatic Disease MISDIAGNOSIS
暂未订购
影响黏液样脂肪肉瘤和黏液纤维肉瘤切除术后预后的因素
7
作者 张远鉴 刘阳 +3 位作者 崔路宽 葛文龙 周士猛 胡永成 《中国矫形外科杂志》 北大核心 2025年第14期1258-1264,共7页
[目的]探讨影响黏液样脂肪肉瘤和黏液纤维肉切除术后预后的因素。[方法]回顾性分析2020年1月-2023年1月本院手术治疗黏液样脂肪肉瘤或黏液纤维肉瘤的22例患者的临床资料,通过单因素比较和单变量Cox风险比例回归分析影响患者预后的因素... [目的]探讨影响黏液样脂肪肉瘤和黏液纤维肉切除术后预后的因素。[方法]回顾性分析2020年1月-2023年1月本院手术治疗黏液样脂肪肉瘤或黏液纤维肉瘤的22例患者的临床资料,通过单因素比较和单变量Cox风险比例回归分析影响患者预后的因素。使用Kaplan–Meier法计算预测生存率,绘制生存曲线,生存差异行Log rank检验。[结果] 22例患者中,14例(64%)接受了根治性切除,另外8例(36%)接受了广泛切除。所有患者随访24~48个月。4例(18%)于术后3~24个月死亡,平均为(13.8±4.4)个月。单因素分析表明:浸润生长者浅表生长的比率显著高于非浸润生长组(P<0.05)。按生长方式分层比较,浸润性生长的实际疾病特异性生存期(disease specific survival, DSS)、实际局部无复发生存期(local failure free survival, LFFS)和实际远处无转移生存期(distant failure free survival, DFFS)均显著短于非浸润性生长(P<0.05),按外科边界分层比较,切缘阴性者的实际DSS、LFFS和DFFS均显著长于切缘阳性者(P<0.05)。单因素Cox风险比例回归表明,生长方式(浸润性生长)的外科边界(切缘阳性)是影响DSS、LFFS和DFFS独立危险因素(P<0.05)。Kaplan-Meier生存分析法预测2年DSS、LFFS和DFFS生存率分别为83%(95%CI:72~94)、83%(95%CI:72~94)和64%(95%CI:50~79)。Log rank检验表明:非浸润生长者的预测DSS[(46.3±1.1)个月vs(26.3±4.2)个月, P=0.001],预测LFFS[(45.4±1.8)个月vs(24.6±4.6)个月,P=0.001]和预测DFFS均显著长于浸润生长者[(43.6±1.7)个月vs(22.8±3.8)个月, P<0.001]。[结论]与非浸润性生长相比,浸润性生长的黏液样脂肪肉瘤和黏液纤维肉瘤的患者预后更差。浸润性生长方式和外科切缘阳性是影响患者预后的独立危险因素。 展开更多
关键词 黏液性脂肪肉瘤 黏液性纤维肉瘤 浸润性生长 预后
原文传递
Idiopathic and radiation-induced myxofibrosarcoma in the head and neck—case report and literature review
8
作者 Bin Zhang Miao Bai +1 位作者 Runfa Tian Shuyu Hao 《Chinese Neurosurgical Journal》 CSCD 2022年第2期133-140,共8页
Background:Myxofibrosarcoma(MFS),especially radiation-Induced MFS(RIMFS)in the head and neck,is an extremely rare malignant fibroblastic tumor.The diagnosis and treatment of MFS remain great challenges.In the present ... Background:Myxofibrosarcoma(MFS),especially radiation-Induced MFS(RIMFS)in the head and neck,is an extremely rare malignant fibroblastic tumor.The diagnosis and treatment of MFS remain great challenges.In the present study,we presented one case of RIMFS.Combined with previous literature,the clinical features,essentials of diagnosis,and treatment modalities of MFS in the head and neck were reviewed to better understand this rare entity.Case presentation:We reported a case of RIMFS under the left occipital scalp in a 20-year-old girl with a history of medulloblastoma surgery and radiotherapy in 2006.A total tumor resection was performed with preservation of the overlying scalp the underlying bone,and no adjuvant therapy was administered after the first operation.The postoperative pathological diagnosis was high-grade MFS.The tumor relapsed 6 months later,and then,a planned extensive resection with negative surgical margins was carried out,followed by radiotherapy.No relapse occurred in a 12-month postoperative follow-up.Conclusions:Planned gross total resection(GTR)with negative margins is the reasonable choice and footstone of other treatments for MFS.Ill-defined infiltrated borders and the complicated structures make it a great trouble to achieve total resection of MFS in the head and neck,so adjuvant radiotherapy and chemotherapy seem more necessary for these lesions. 展开更多
关键词 myxofibrosarcoma Head and neck Planned surgery Gross total resection Bin Zhang and Miao Bai are co-first authors
原文传递
α-SMA和梭形细胞Vimentin的表达及其与黏液纤维肉瘤患者预后的关系
9
作者 吴国慧 张燕 《肿瘤防治研究》 2025年第9期736-740,共5页
目的 分析α-平滑肌肌动蛋白(α-SMA)和梭形细胞Vimentin的表达及其与黏液纤维肉瘤(MFS)患者预后的关系。方法 收集2018年1月至2021年1月在中国人民解放军总医院第四医学中心收治的61例MFS患者的影像学资料、临床及病理学资料,所有MFS... 目的 分析α-平滑肌肌动蛋白(α-SMA)和梭形细胞Vimentin的表达及其与黏液纤维肉瘤(MFS)患者预后的关系。方法 收集2018年1月至2021年1月在中国人民解放军总医院第四医学中心收治的61例MFS患者的影像学资料、临床及病理学资料,所有MFS患者均经术后病理学检查证实。免疫组织化学法测定MFS患者α-SMA和梭形细胞Vimentin的阳性比例并分析α-SMA和梭形细胞Vimentin表达与预后的相关性。结果 在MFS组织中α-SMA和Vimentin阳性表达率分别为68.85%和60.66%;Vimentin的表达与3年总生存期(OS)及无病生存期(DFS)无显著性相关(P=0.351,P=0.284),α-SMA的表达与OS、DFS显著相关(P=0.030,P=0.017),α-SMA高表达患者的OS、DFS较短。结论 测定α-SMA水平有助于评估MFS患者预后,从而指导临床治疗。 展开更多
关键词 Α-SMA 梭形细胞Vimentin 黏液纤维肉瘤
暂未订购
胰腺黏液纤维肉瘤MRI表现一例并文献复习
10
作者 张曼曼 李旭 +2 位作者 马培旗 张小艳 张磊 《磁共振成像》 CAS CSCD 北大核心 2024年第8期179-180,193,共3页
本文为回顾性研究,遵守《赫尔辛基宣言》,经过阜阳市人民医院伦理委员会批准,免除受试者知情同意,批准文号:[2021]-55号。患者女,80岁,于一年前无明显诱因下出现左中上腹疼痛,呈持续性隐痛,程度轻微,伴腹胀不适,未予重视治疗,近10天来... 本文为回顾性研究,遵守《赫尔辛基宣言》,经过阜阳市人民医院伦理委员会批准,免除受试者知情同意,批准文号:[2021]-55号。患者女,80岁,于一年前无明显诱因下出现左中上腹疼痛,呈持续性隐痛,程度轻微,伴腹胀不适,未予重视治疗,近10天来患者左上腹疼痛加重。 展开更多
关键词 黏液纤维肉瘤 胰腺肿瘤 磁共振成像
暂未订购
四肢躯干低度恶性纤维黏液肉瘤与黏液纤维肉瘤的临床病理比较分析 被引量:14
11
作者 黄晓赤 罗克枢 +2 位作者 吴蓉宜 赵剑萍 唐艳 《临床与实验病理学杂志》 CAS CSCD 北大核心 2009年第2期166-170,共5页
目的探讨发生在躯干肢体5例低度恶性的纤维黏液肉瘤(low-grade fibromyxoid sarcoma,LGFMS)和4例黏液纤维肉瘤(myxofibro sarcoma,MFS)的临床病理特征、生物学行为、诊断和鉴别诊断。方法分析5例LGFMS的临床病理资料、大体形态、组织学... 目的探讨发生在躯干肢体5例低度恶性的纤维黏液肉瘤(low-grade fibromyxoid sarcoma,LGFMS)和4例黏液纤维肉瘤(myxofibro sarcoma,MFS)的临床病理特征、生物学行为、诊断和鉴别诊断。方法分析5例LGFMS的临床病理资料、大体形态、组织学特点、免疫组化标记和预后,并与4例MFS相比较。结果两类肿瘤能够在组织形态学方面进行鉴别,LGFMS由梭形细胞构成,具有黏液区和纤维间质交替分布的特点。肿瘤细胞无异型性,肿瘤组织无坏死。MFS以细长弯曲的薄壁血管和脂母细胞样细胞为特征,伴有丰富的黏液区而没有大面积的实性区,有肿瘤性坏死。两类肿瘤在免疫组化标记、肿瘤位置和患者的年龄方面也有差别。结论LGFMS是一种罕见肿瘤,临床病理及生物学行为与MFS不同,二者可以通过临床病理特点进行鉴别,LGFMS较之MFS有更好的预后。 展开更多
关键词 软组织肿瘤 纤维黏液肉瘤 黏液纤维肉瘤 预后
暂未订购
纤维组织源性肿瘤的CT与MRI表现与组织病理学对照 被引量:10
12
作者 张琳 汤光宇 +3 位作者 姚建华 赵文荣 陈云燕 王骐 《临床放射学杂志》 CSCD 北大核心 2013年第6期855-859,共5页
目的探讨软组织侵袭性纤维瘤病、恶性纤维组织细胞瘤和黏液纤维肉瘤的CT与MRI表现及其组织病理性基础。方法回顾性分析经手术病理证实的软组织侵袭性纤维瘤病(7例)、恶性纤维组织细胞瘤(9例)、黏液纤维肉瘤(3例)的CT和MRI表现,并与病理... 目的探讨软组织侵袭性纤维瘤病、恶性纤维组织细胞瘤和黏液纤维肉瘤的CT与MRI表现及其组织病理性基础。方法回顾性分析经手术病理证实的软组织侵袭性纤维瘤病(7例)、恶性纤维组织细胞瘤(9例)、黏液纤维肉瘤(3例)的CT和MRI表现,并与病理表现对照。结果共检出肿瘤23个。侵袭性纤维瘤病7个,2个呈膨胀性生长,5个呈浸润性生长,CT像上呈等低密度,T1WI上呈低信号,T2WI/FS上信号明显增高。肿块内夹杂线样、条索状低信号影,增强扫描强化不均匀;恶性纤维组织细胞瘤12个,均呈分叶状,边界模糊,密度/信号不均匀,常伴囊变、坏死,增强扫描实质部分呈明显欠均匀强化。黏液纤维肉瘤4个,2个呈膨胀性生长,2个呈浸润性生长,密度/信号混杂,MRI可清晰显示黏液样基质的特征性信号,T2WI上呈高亮信号。结论软组织侵袭性纤维瘤病、恶性纤维组织细胞瘤、黏液纤维肉瘤均为纤维组织来源肿瘤,影像学见瘤体内数量不同的线样低密度或低信号影,但又有各自影像特点,与其不同的病理学基础密切相关。MRI在反映病灶内成分方面优于CT。 展开更多
关键词 软组织肿瘤 纤维瘤病 侵袭型 恶性纤维组织细胞瘤 黏液纤维肉瘤 磁共振成像 体层摄影术 X线计算机 病理学
原文传递
软组织黏液纤维肉瘤的超声表现 被引量:5
13
作者 唐小兰 唐远姣 +1 位作者 向茜 邱逦 《中国介入影像与治疗学》 CSCD 北大核心 2016年第9期557-561,共5页
目的 探讨软组织黏液纤维肉瘤(MFS)的超声表现。方法 回顾性分析经病理学证实的12例软组织MFS超声表现,并对不同组织病理学级别病灶进行比较。结果12例MFS患者的中位年龄为51岁,其中11例(11/12,91.67%)为男性;8例(8/12,66.67%)高... 目的 探讨软组织黏液纤维肉瘤(MFS)的超声表现。方法 回顾性分析经病理学证实的12例软组织MFS超声表现,并对不同组织病理学级别病灶进行比较。结果12例MFS患者的中位年龄为51岁,其中11例(11/12,91.67%)为男性;8例(8/12,66.67%)高级别MFS,4例中低级别MFS;8例(8/12,66.67%)发生于四肢,4例(4/12,33.33%)发生于躯干;6例(6/12,50.00%)单发;7例(7/12,58.33%)出现术后原位复发。超声表现:均为实性弱回声团块,其中10例(10/12,83.33%)位于皮下层,2例(2/12,16.67%)位于肌层;肿瘤最大径约(34.08±21.90)mm;9例(9/12,75.00%)边界不清楚、形态不规则;11例(11/12,91.67%)内部回声不均匀。1例高级别MFS出现局部淋巴结转移。CDFI显示8例(8/12,66.67%)为0~1级血流,4例(4/12,33.33%)2~3级血流。高级别与中低级别组比较:边界、形态的差异均有统计学意义(P均〈0.05),而病灶位置、病变大小、淋巴结转移、有无复发、病变数目、内部回声、有无坏死及血流分级上的差异均无统计学意义(P均〉0.05)。结论 MFS的超声图像均表现为实性弱回声病灶,多数边界不清楚,形态不规则,内部回声不均匀。高级别MFS多表现为边界不清楚、形态不规则。 展开更多
关键词 黏液纤维肉瘤 超声检查 组织病理学
暂未订购
肝脏原发黏液性纤维肉瘤CT及MRI影像特征分析 被引量:2
14
作者 祁佩红 张斯佳 +3 位作者 窦社伟 李四保 朱绍成 刘志敏 《中华实用诊断与治疗杂志》 2023年第9期870-873,共4页
目的观察肝脏原发黏液性纤维肉瘤(MFS)的CT、MRI影像表现,探讨其影像学特征。方法回顾性分析2005年5月—2020年2月郑州人民医院经术后组织病理检查证实的5例肝脏原发MFS患者的CT、MRI影像资料。结果5例中病灶单发4例,多发1例。例3出现... 目的观察肝脏原发黏液性纤维肉瘤(MFS)的CT、MRI影像表现,探讨其影像学特征。方法回顾性分析2005年5月—2020年2月郑州人民医院经术后组织病理检查证实的5例肝脏原发MFS患者的CT、MRI影像资料。结果5例中病灶单发4例,多发1例。例3出现上腹部疼痛,余4例无明显不适。5例CT平扫显示肿块直径6.2~18.5 cm,中位直径13.5 cm;肿块均表现为较大囊实性不均匀低密度影,肿块内部可见条索状或云絮状分隔;例4边界清晰,另4例边界模糊;例1、例2边缘为浅分叶,例3、例4、例5为深分叶;例1、例3、例5突破肝包膜,侵及膈肌;除例4外肿瘤呈浸润性生长。MRI结果显示肿块含黏液的囊性成分均呈等T_(1)稍长T_(2)信号或稍短T_(1)等T_(2)信号,弥散加权成像呈稍高、高信号;部分呈长T_(1)、长T_(2)信号,弥散加权成像呈低信号;肿块周边可见实性结节,部分呈菜花状等T_(1)、等T_(2)信号,病灶内见条索样式或云絮状分隔呈等T_(1)等T_(2)信号,部分边界不清,弥散加权成像均呈高信号。CT及MRI增强扫描均显示肿块内囊液无强化,其内结节、分隔、囊壁呈渐进性轻中度强化;例3和例5 CT增强扫描动脉期可见瘤内弯曲小血管影。结论肝脏内出现较大囊实性肿块,肿块内含黏液成分,肿块内部周边可见结节及条索状、云絮状分隔,增强后结节、分隔及囊壁呈渐进性强化,肿瘤有浸润性生长特性,应考虑肝脏原发MFS可能,行多模态MRI扫描有助于黏液成分的诊断。 展开更多
关键词 黏液纤维肉瘤 肝脏 CT MRI 影像特征
原文传递
心脏黏液性纤维肉瘤术后并下肢软组织转移1例 被引量:1
15
作者 宋越 严天慰 +4 位作者 谢明星 雷炳松 王静 王斌 余铖 《中国医学影像技术》 CSCD 北大核心 2015年第10期1612-1612,共1页
患者女,34岁。10个月前于外院超声心动图提示二尖瓣前叶实质性占位性病变并二尖瓣重度关闭不全(图1),行二尖瓣肿瘤切除术并二尖瓣生物瓣置换术,病理诊断为二尖瓣前叶黏液瘤(图2)。后因“进行性腿部疼痛1个月”入院。杏体:右侧... 患者女,34岁。10个月前于外院超声心动图提示二尖瓣前叶实质性占位性病变并二尖瓣重度关闭不全(图1),行二尖瓣肿瘤切除术并二尖瓣生物瓣置换术,病理诊断为二尖瓣前叶黏液瘤(图2)。后因“进行性腿部疼痛1个月”入院。杏体:右侧小腿可触及约30.0mm×20.0mm的肿块,中等硬度、活动度差,有触痛、局部皮肤有色素沉积。实验室检查CA125为270.80U/ml。 展开更多
关键词 黏液性纤维肉瘤 肿瘤转移 超声检查
暂未订购
甲状腺原发性黏液纤维肉瘤临床病理观察 被引量:1
16
作者 宣兰兰 戴瑜珍 +1 位作者 杨海燕 鲍方 《诊断病理学杂志》 CSCD 2016年第12期942-945,共4页
目的探讨原发于甲状腺罕见的黏液纤维肉瘤(MFS)的临床病理特征、诊断及鉴别诊断。方法对1例甲状腺原发性黏液纤维肉瘤的临床表现、组织学形态及免疫组化进行分析,并复习相关文献。结果患者男性,71岁。颈部增强CT及彩超示双侧甲状腺内... 目的探讨原发于甲状腺罕见的黏液纤维肉瘤(MFS)的临床病理特征、诊断及鉴别诊断。方法对1例甲状腺原发性黏液纤维肉瘤的临床表现、组织学形态及免疫组化进行分析,并复习相关文献。结果患者男性,71岁。颈部增强CT及彩超示双侧甲状腺内占位性病变。光镜下肿瘤由纤维结缔组织分隔呈多结节状,肿瘤细胞为梭形或星芒状,呈紊乱或条束状排列于黏液样间质中,可见具有形态学特征的多空泡假脂肪母细胞,以及间质中曲线状或弧线状血管。免疫组化示vimentin(+),CKpan、TG、TTF1、PAX-8、calcitonin、Syn、Cg A、CD34、S-100蛋白、SMA、desmin、EMA和CD68均(-),Ki-67阳性率10%~15%。结论甲状腺原发性黏液纤维肉瘤极其罕见,临床病理诊断较困难,应排除转移性软组织肿瘤、甲状腺常见肿瘤及其他类似肿瘤,需结合病理形态和免疫组化标记确诊。该肿瘤的治疗方式为手术扩大切除并术后辅助放疗。 展开更多
关键词 甲状腺 黏液纤维肉瘤 免疫组化 鉴别诊断
原文传递
肾盂输尿管黏液纤维肉瘤超声表现1例 被引量:1
17
作者 唐小兰 邱逦 《中国医学影像技术》 CSCD 北大核心 2016年第6期909-909,共1页
患者女,41岁,因"间断性全程肉眼血尿2个月,右腰部阵发性钝痛10天"入院。查体:右上腹扪及大小约5.0cm×7.0cm的包块,右肾肋下可触及。超声检查:右侧肾盂及肾盏被巨大囊实混合回声团占据,大小约4.0cm×5.0cm×5.5cm,边界... 患者女,41岁,因"间断性全程肉眼血尿2个月,右腰部阵发性钝痛10天"入院。查体:右上腹扪及大小约5.0cm×7.0cm的包块,右肾肋下可触及。超声检查:右侧肾盂及肾盏被巨大囊实混合回声团占据,大小约4.0cm×5.0cm×5.5cm,边界不清,形态不规则,内可见片状无回声区,右侧输尿管上段扩张. 展开更多
关键词 黏液纤维肉瘤 超声检查 肾盂输尿管
暂未订购
阿帕替尼致咯血并心律失常1例分析
18
作者 青晓艳 曾晓梅 《中国药物警戒》 2021年第9期890-893,共4页
目的分析阿帕替尼治疗晚期肉瘤过程中出现的不良反应特点。方法总结1例晚期黏液纤维肉瘤患者服用阿帕替尼后出现不良反应的病例,并复习相关文献。结果阿帕替尼已被证明在标准多模式治疗失败后能延长晚期肉瘤的无进展生存期。本例晚期黏... 目的分析阿帕替尼治疗晚期肉瘤过程中出现的不良反应特点。方法总结1例晚期黏液纤维肉瘤患者服用阿帕替尼后出现不良反应的病例,并复习相关文献。结果阿帕替尼已被证明在标准多模式治疗失败后能延长晚期肉瘤的无进展生存期。本例晚期黏液纤维肉瘤经多线治疗后予阿帕替尼单药靶向治疗,无进展生存期达到5个月。患者在治疗过程中,合并咯血、心律失常,考虑药品不良反应所致,心律失常在停药2周后得到纠正,后期患者出现不完全性肠梗阻,将阿帕替尼减量治疗,后肠梗阻逐渐减轻。随后患者出现Ⅲ°血小板减少,考虑阿帕替尼所致重度骨髓抑制,患者在用药过程中出现一系列不良反应,给予动态评估及动态调整阿帕替尼用法用量,取得了良好的疾病客观缓解,其中重度骨髓抑制是一种新的、严重的药品不良反应。结论应加强阿帕替尼在晚期肉瘤中的用药监测,本案例中,医师及时、准确地获取和确诊相关症状并施以针对性的治疗方案,为阿帕替尼个体化合理使用与及时发现和诊断提供了宝贵的临床经验和指导。 展开更多
关键词 阿帕替尼 黏液纤维肉瘤 不良反应 骨髓抑制
暂未订购
左心房纤维黏液肉瘤1例
19
作者 刘燕 《中国医学影像技术》 CSCD 北大核心 2017年第4期509-509,共1页
患者女,34岁,主因“胸闷、气短半个月,突发头痛伴恶心、呕吐4天”入院。查体:血压94 mmHg/52 mmHg,心律齐,心尖部可闻及肿瘤扑落音。心电图提示窦性心动过速,P-R间期缩短,T波改变。
关键词 纤维黏液肉瘤 心脏肿瘤 超声心动描记术
暂未订购
结肠息肉状黏液纤维肉瘤1例并文献复习
20
作者 何珏 陈检娣 《世界华人消化杂志》 CAS 2015年第9期1535-1538,共4页
黏液纤维肉瘤(myxofibrosarcoma,MFS)是少见的软组织恶性肿瘤,有其独特的临床病理特征;发生于结肠并呈息肉状生长者罕见.本例患者女性,55岁,因腹痛伴便血1 wk就诊,电子肠镜检查见升结肠息肉样肿块入院,外科行部分结肠切除术.术后病理诊... 黏液纤维肉瘤(myxofibrosarcoma,MFS)是少见的软组织恶性肿瘤,有其独特的临床病理特征;发生于结肠并呈息肉状生长者罕见.本例患者女性,55岁,因腹痛伴便血1 wk就诊,电子肠镜检查见升结肠息肉样肿块入院,外科行部分结肠切除术.术后病理诊断:结肠息肉状黏液纤维肉瘤(1级).本例报告丰富完善了MFS的理论体系,对该肿瘤的临床诊治会产生积极的影响. 展开更多
关键词 结肠 免疫组织化学 临床病理 黏液纤维肉瘤
暂未订购
上一页 1 2 下一页 到第
使用帮助 返回顶部